Next Article in Journal
The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010–2015: The Experience of Sicily and Liguria
Next Article in Special Issue
NAFLD and Chronic Kidney Disease
Previous Article in Journal
The Long Intron 1 of Growth Hormone Gene from Reeves’ Turtle (Chinemys reevesii) Correlates with Negatively Regulated GH Expression in Four Cell Lines
Previous Article in Special Issue
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(4), 548; doi:10.3390/ijms17040548

Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD

Department of Pathophysiology and Transplantation, IRCCS “Ca’ Granda” IRCCS Foundation, Poiliclinico Hospital, University of Milan, Centro delle Malattie Metaboliche del Fegato, Milan 20122, Italy
Author to whom correspondence should be addressed.
Academic Editors: Amedeo Lonardo and Giovanni Targher
Received: 3 March 2016 / Revised: 1 April 2016 / Accepted: 5 April 2016 / Published: 12 April 2016
(This article belongs to the Special Issue Non-Alcoholic Fatty Liver Disease Research 2016)
View Full-Text   |   Download PDF [605 KB, uploaded 12 April 2016]   |  


Nonalcoholic fatty liver disease (NAFLD), tightly linked to the metabolic syndrome (MS), has emerged as a leading cause of chronic liver disease worldwide. Since it is potentially progressive towards non-alcoholic steatohepatitis (NASH) and hepatic fibrosis, up to cirrhosis and its associated complications, the need for predictive factors of NAFLD and of its advanced forms is mandatory. Despite the current “gold standard” for the assessment of liver damage in NAFLD being liver biopsy, in recent years, several non-invasive tools have been designed as alternatives to histology, of which fibroscan seems the most promising. Among the different serum markers considered, serum uric acid (SUA) and ferritin have emerged as possible predictors of severity of liver damage in NAFLD. In fact, as widely described in this review, they share common pathogenetic pathways and are both associated with hepatic steatosis and MS, thus suggesting a likely synergistic action. Nevertheless, the power of these serum markers seems to be too low if considered alone, suggesting that they should be included in a wider perspective together with other metabolic and biochemical parameters in order to predict liver damage. View Full-Text
Keywords: SUA; liver damage; fibrosis; NASH; serum markers; oxidative stress; insulin resistance; metabolic syndrome SUA; liver damage; fibrosis; NASH; serum markers; oxidative stress; insulin resistance; metabolic syndrome

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lombardi, R.; Pisano, G.; Fargion, S. Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. Int. J. Mol. Sci. 2016, 17, 548.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top